Article info

Download PDFPDF

Pharmacovigilance assessment of the association between Fournier’s gangrene and other severe genital adverse events with SGLT-2 inhibitors

Authors

  1. Correspondence to Professor Gian Paolo Fadini; gianpaolofadini{at}hotmail.com
View Full Text

Citation

Fadini GP, Sarangdhar M, De Ponti F, et al
Pharmacovigilance assessment of the association between Fournier’s gangrene and other severe genital adverse events with SGLT-2 inhibitors

Publication history

  • Received July 6, 2019
  • Revised August 14, 2019
  • Accepted September 12, 2019
  • First published October 4, 2019.
Online issue publication 
October 04, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.